• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拉沙病毒核蛋白(NP)的DEDDh 3'-5'外切核糖核酸酶活性对于最佳病毒RNA复制和突变控制是必需的。

Lassa virus NP DEDDh 3'-5' exoribonuclease activity is required for optimal viral RNA replication and mutation control.

作者信息

Huang Cheng, Mantlo Emily, Paessler Slobodan

机构信息

Department of Pathology, Galveston National Laboratory and Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.

Current address: Department of Microbiology & Immunology, Upstate Medical University, Syracuse, NY, USA.

出版信息

bioRxiv. 2023 Dec 30:2023.04.12.536665. doi: 10.1101/2023.04.12.536665.

DOI:10.1101/2023.04.12.536665
PMID:37090668
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10120729/
Abstract

Lassa virus (LASV), a mammarenavirus from , is the causative agent of Lassa fever (LF) endemic in West Africa. Currently, there are no vaccines or antivirals approved for LF. The RNA-dependent RNA polymerases (RdRp) of RNA viruses are error-prone. As a negative-sense RNA virus, how LASV copes with errors in RNA synthesis and ensures optimal RNA replication are not well elucidated. LASV nucleoprotein (NP) contains a DEDDH 3'-to-5' exoribonuclease motif (ExoN), which is known to be essential for LASV evasion of the interferon response via its ability to degrade virus-derived double-stranded RNA. Herein, we present evidence that LASV NP ExoN has an additional function important for viral RNA replication. We rescued an ExoN-deficient LASV mutant (ExoN- rLASV) by using a reverse genetics system. Our data indicated that abrogation of NP ExoN led to impaired LASV growth and RNA replication in interferon-deficient cells as compared with wild-type rLASV. By utilizing PacBio Single Molecule, Real-Time (SMRT) long-read sequencing technology, we found that rLASV lacking ExoN activity was prone to producing aberrant viral genomic RNA with structural variations. In addition, NP ExoN deficiency enhanced LASV sensitivity to mutagenic nucleoside analogues in virus titration assay. Next-generation deep sequencing analysis showed increased single nucleotide substitution in ExoN- LASV RNA following mutagenic 5-flurouracil treatment. In conclusion, our study revealed that LASV NP ExoN is required for efficient viral RNA replication and mutation control. Among negative-sense RNA viruses, LASV NP is the first example that a viral protein, other than the RdRp, contributes to reduce errors in RNA replication and maintain genomic RNA integrity. These new findings promote our understanding of the basics of LASV infection and inform antiviral and vaccine development.

摘要

拉沙病毒(LASV)是一种来自沙粒病毒科的哺乳动物病毒,是西非地方性拉沙热(LF)的病原体。目前,尚无获批用于拉沙热的疫苗或抗病毒药物。RNA病毒的RNA依赖性RNA聚合酶(RdRp)容易出错。作为一种负链RNA病毒,拉沙病毒如何应对RNA合成中的错误并确保最佳RNA复制尚不清楚。拉沙病毒核蛋白(NP)含有一个DEDDH 3'至5'外切核糖核酸酶基序(ExoN),已知该基序对于拉沙病毒通过降解病毒衍生的双链RNA逃避干扰素反应至关重要。在此,我们提供证据表明拉沙病毒NP ExoN对病毒RNA复制具有重要的额外功能。我们使用反向遗传学系统拯救了一种ExoN缺陷型拉沙病毒突变体(ExoN - rLASV)。我们的数据表明,与野生型rLASV相比,NP ExoN的缺失导致拉沙病毒在干扰素缺陷细胞中的生长和RNA复制受损。通过利用PacBio单分子实时(SMRT)长读长测序技术,我们发现缺乏ExoN活性的rLASV易于产生具有结构变异的异常病毒基因组RNA。此外,在病毒滴定试验中,NP ExoN缺陷增强了拉沙病毒对诱变核苷类似物的敏感性。下一代深度测序分析显示,诱变5 - 氟尿嘧啶处理后,ExoN - 拉沙病毒RNA中的单核苷酸替换增加。总之,我们的研究表明拉沙病毒NP ExoN是高效病毒RNA复制和突变控制所必需的。在负链RNA病毒中,拉沙病毒NP是第一个除RdRp外,有助于减少RNA复制错误并维持基因组RNA完整性的病毒蛋白实例。这些新发现促进了我们对拉沙病毒感染基础的理解,并为抗病毒和疫苗开发提供了信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/42a109535fef/nihpp-2023.04.12.536665v2-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/dc5af2700256/nihpp-2023.04.12.536665v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/c542c2471a26/nihpp-2023.04.12.536665v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/71571a70820c/nihpp-2023.04.12.536665v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/7e31bfc4ce0c/nihpp-2023.04.12.536665v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/459c5b4e91a3/nihpp-2023.04.12.536665v2-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/ef530f04a708/nihpp-2023.04.12.536665v2-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/2566e69c9169/nihpp-2023.04.12.536665v2-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/cdbca80148ed/nihpp-2023.04.12.536665v2-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/357d40289fd8/nihpp-2023.04.12.536665v2-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/42a109535fef/nihpp-2023.04.12.536665v2-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/dc5af2700256/nihpp-2023.04.12.536665v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/c542c2471a26/nihpp-2023.04.12.536665v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/71571a70820c/nihpp-2023.04.12.536665v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/7e31bfc4ce0c/nihpp-2023.04.12.536665v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/459c5b4e91a3/nihpp-2023.04.12.536665v2-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/ef530f04a708/nihpp-2023.04.12.536665v2-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/2566e69c9169/nihpp-2023.04.12.536665v2-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/cdbca80148ed/nihpp-2023.04.12.536665v2-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/357d40289fd8/nihpp-2023.04.12.536665v2-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0a/10760335/42a109535fef/nihpp-2023.04.12.536665v2-f0010.jpg

相似文献

1
Lassa virus NP DEDDh 3'-5' exoribonuclease activity is required for optimal viral RNA replication and mutation control.拉沙病毒核蛋白(NP)的DEDDh 3'-5'外切核糖核酸酶活性对于最佳病毒RNA复制和突变控制是必需的。
bioRxiv. 2023 Dec 30:2023.04.12.536665. doi: 10.1101/2023.04.12.536665.
2
Lassa Virus, but Not Highly Pathogenic New World Arenaviruses, Restricts Immunostimulatory Double-Stranded RNA Accumulation during Infection.拉沙病毒,但不是高致病性新世界沙粒病毒,限制了感染过程中免疫刺激性双链 RNA 的积累。
J Virol. 2020 Apr 16;94(9). doi: 10.1128/JVI.02006-19.
3
A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene.基于病毒糖蛋白基因密码子去优化的拉沙热减毒活疫苗。
mBio. 2020 Feb 25;11(1):e00039-20. doi: 10.1128/mBio.00039-20.
4
A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region.基于基因间区重排的拉沙病毒活疫苗候选株。
mBio. 2020 Mar 24;11(2):e00186-20. doi: 10.1128/mBio.00186-20.
5
Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays.表达绿色荧光蛋白的重组拉沙病毒作为高通量药物筛选和中和抗体检测的工具。
Viruses. 2018 Nov 20;10(11):655. doi: 10.3390/v10110655.
6
A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins.基于表达异源糖蛋白的重组高度减毒 Mopeia 病毒的沙粒病毒疫苗平台。
J Virol. 2018 May 29;92(12). doi: 10.1128/JVI.02230-17. Print 2018 Jun 15.
7
Combating Lassa Fever in West African Sub-Region: Progress, Challenges, and Future Perspectives.西非分区域抗击拉沙热:进展、挑战和未来展望。
Viruses. 2023 Jan 3;15(1):146. doi: 10.3390/v15010146.
8
Hexestrol, an estrogen receptor agonist, inhibits Lassa virus entry.己烯雌酚,一种雌激素受体激动剂,可抑制拉沙病毒进入。
J Virol. 2024 Jul 23;98(7):e0071424. doi: 10.1128/jvi.00714-24. Epub 2024 May 29.
9
Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever.展示所有主要免疫决定簇的拉沙病毒样颗粒,可用作拉沙热出血热的候选疫苗。
Virol J. 2010 Oct 20;7:279. doi: 10.1186/1743-422X-7-279.
10
An mRNA-LNP-based Lassa virus vaccine induces protective immunity in mice.一种基于信使核糖核酸-脂质纳米颗粒的拉沙病毒疫苗可在小鼠体内诱导产生保护性免疫。
J Virol. 2024 Jun 13;98(6):e0057824. doi: 10.1128/jvi.00578-24. Epub 2024 May 20.

本文引用的文献

1
Isolation of Reconstructed Functional Ribonucleoprotein Complexes of Machupo Virus.Machupo 病毒重建功能性核糖核蛋白复合物的分离。
J Virol. 2021 Oct 27;95(22):e0105421. doi: 10.1128/JVI.01054-21. Epub 2021 Aug 25.
2
Twelve years of SAMtools and BCFtools.SAMtools 和 BCFtools 十二年。
Gigascience. 2021 Feb 16;10(2). doi: 10.1093/gigascience/giab008.
3
Animal Models of Lassa Fever.拉沙热的动物模型
Pathogens. 2020 Mar 6;9(3):197. doi: 10.3390/pathogens9030197.
4
Single-molecular real-time deep sequencing reveals the dynamics of multi-drug resistant haplotypes and structural variations in the hepatitis C virus genome.单分子实时深度测序揭示丙型肝炎病毒基因组中耐药单倍型和结构变异的动态。
Sci Rep. 2020 Feb 14;10(1):2651. doi: 10.1038/s41598-020-59397-2.
5
Lassa Virus, but Not Highly Pathogenic New World Arenaviruses, Restricts Immunostimulatory Double-Stranded RNA Accumulation during Infection.拉沙病毒,但不是高致病性新世界沙粒病毒,限制了感染过程中免疫刺激性双链 RNA 的积累。
J Virol. 2020 Apr 16;94(9). doi: 10.1128/JVI.02006-19.
6
Differential Immune Responses to Hemorrhagic Fever-Causing Arenaviruses.对引起出血热的沙粒病毒的差异性免疫反应。
Vaccines (Basel). 2019 Oct 2;7(4):138. doi: 10.3390/vaccines7040138.
7
Small-Molecule Antiviral β-d--Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance.小分子抗病毒药物 β-d--羟基胞苷能抑制未经校正的冠状病毒,该病毒对耐药性有很高的遗传屏障。
J Virol. 2019 Nov 26;93(24). doi: 10.1128/JVI.01348-19. Print 2019 Dec 15.
8
The Curious Case of the Nidovirus Exoribonuclease: Its Role in RNA Synthesis and Replication Fidelity.尼多病毒外切核糖核酸酶的奇妙案例:其在RNA合成和复制保真度中的作用
Front Microbiol. 2019 Aug 7;10:1813. doi: 10.3389/fmicb.2019.01813. eCollection 2019.
9
Defective viral genomes are key drivers of the virus-host interaction.缺陷型病毒基因组是病毒-宿主相互作用的关键驱动因素。
Nat Microbiol. 2019 Jul;4(7):1075-1087. doi: 10.1038/s41564-019-0465-y. Epub 2019 Jun 3.
10
Measures to control protracted large Lassa fever outbreak in Nigeria, 1 January to 28 April 2019.2019 年 1 月 1 日至 4 月 28 日尼日利亚控制长期大规模拉沙热疫情的措施。
Euro Surveill. 2019 May;24(20). doi: 10.2807/1560-7917.ES.2019.24.20.1900272.